ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988

Enter The Cancer Letter’s 35th Anniversary Story Contest

July 31, 2009

DCPC Board Okays Concept For $10 Mil. Program to Promote Cancer Management In Rural Areas

May 25, 1990

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990

It is The First FDA Withdrawl Of An Accelerated Approval

November 18, 2011

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014